Literature DB >> 2839668

Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.

A Wellstein1, G G Belz, D Palm.   

Abstract

In the present study we investigated whether the beta adrenoceptor subtype binding activity in plasma samples can predict selective and nonselective beta blockade in humans. From the right shifts of isoprenaline dose-response curves 0 to 84 hr after administration of propranolol and the beta-1 selective bisoprolol, in vivo beta blockade was assessed. In an in vitro radioreceptor assay with membrane preparations of beta-1 or beta-2 adrenoceptors, plasma samples were assayed for subtype selective blocking activity. After propranolol administration, in vitro beta-1 and beta-2 adrenoceptor occupancy declined from initially 97% to less than 10% within 48 hr. An isoprenaline dose ratio (DR)-1 of 1 coincided with a 50% occupancy of the beta-1 or the beta-2 subtype in vitro. In Schild-plots using plasma concentrations (radioreceptor assay) and the isoprenaline DR-1 for heart rate, diastolic blood pressure and inotropy (QS2C), slopes of unity were observed. After bisoprolol administration, in vitro beta-1 occupancy shifted from initially 95% to less than 10% within 72 hr. For the beta-2 subtype, an occupancy of greater than 10% was detectable only within the first 12 hr. An isoprenaline DR-1 of 1 coincided with a 50% occupancy of beta-1 adrenoceptors. The bisoprolol Schild-plots yielded a slope of unity for inotropy, but less than unity for the heart rate and diastolic blood pressure. From an extended analysis of subtype selective antagonism in Schild-plots, the fractions of the beta-2 adrenoceptor subtype participating in the isoprenaline response were calculated: heart rate 0.45 +/- 0.12 and diastolic blood pressure 0.23 +/- 0.13. It is concluded that in vitro receptor occupancy can predict beta blockade in humans for propranolol. Beta adrenoceptor subtype-mediated effects in humans can be evaluated with a selective antagonist and a refined analysis of Schild-plot data.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839668

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

1.  Comparison of non-invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: sex differences in cardiovascular responsiveness.

Authors:  M Wolzt; L Schmetterer; A Rheinberger; A Salomon; C Unfried; H Breiteneder; H Ehringer; H G Eichler; A F Fercher
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

2.  Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.

Authors:  K Breithaupt-Grögler; M Leschinger; G G Belz; R Butzer; K Erb; C de May; W Sinn
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.

Authors:  K Taguchi; R F Schäfers; M C Michel
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

4.  Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP.

Authors:  H Lemoine; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

5.  Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies.

Authors:  C De Mey; K Breithaupt-Grögler; J Schloos; D Palm; G G Belz
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Disagreement between standard transthoracic impedance cardiography and the automated transthoracic electrical bioimpedance method in estimating the cardiovascular responses to phenylephrine and isoprenaline in healthy man.

Authors:  C De Mey; D Enterling
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

Review 7.  Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.

Authors:  Gustav G Belz
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

8.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.

Authors:  P Bremner; C Burgess; G Purdie; R Beasley; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.

Authors:  C de Mey; K Beithaupt; D Palm; U Fuhr; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Beta adrenoreceptor subtype cross regulation in the human heart.

Authors:  J A Hall; A Ferro; J E Dickerson; M J Brown
Journal:  Br Heart J       Date:  1993-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.